C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/26 (2006.01) A61K 38/20 (2006.01) C07K 14/54 (2006.01) C07K 14/55 (2006.01) C07K 16/24 (2006.01) C12N 15/24 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2186854
Novel splice mutants of interleukins-2 and 4 are disclosed, which contain exons 1, 3 and 4 of the full-length mRNAs, but have exon 2 deleted. The proteins resulting from the expression of these splice mutants are useful in regulating the activity of the full-length interleukins.
La présente invention concerne de nouveaux mutants des interleukines 2 et 4 obtenus par épissage, ces mutants comportant les exons 1, 3 et 4 des ARNm pleine longueur, auxquels il manque cependant l'exon 2. Les protéines issues de l'expression de ces mutants obtenus par épissage sont utiles pour la régulation de l'activité des interleukines pleine longueur.
Alms William J.
White Barbara
Mccarthy Tetrault Llp
University Of Maryland At Baltimore
LandOfFree
Human interleukin variants generated by alternative splicing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human interleukin variants generated by alternative splicing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human interleukin variants generated by alternative splicing will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1865178